Introduction: Choosing between different non-vitamin K antagonist oral anticoagulants (NOACs)
in non-valvular atrial fibrillation (NVAF) is difficult due to the absence of head to head …

… Novel oral anticoagulants (NOACs) have been approved for prevention of stroke and
systemic … We intended to evaluate the safety and efficacy of NOACs for AF ablation during the …

… Evidence on the use of nonvitamin K antagonist oral anticoagulants ( NOAC s) in patients …
aimed to determine the safety and efficacy of periprocedural anticoagulation with NOAC s …

… to overcome the limitations of the conventional anticoagulant drugs. However, models to …
new oral anticoagulants. This review will briefly describe the new oral anticoagulants dabigatran…

… on the use of anticoagulation therapy in Chinese non-… data on the safety and efficacy of
anticoagulation therapy in Chinese … investigate the safety and efficacy of anticoagulation among …

BACKGROUND Direct oral anticoagulants (DOACs) are effective and safe for prophylaxis
and treatment of thromboembolic phenomena. However, managing DOACs during bleeding …

… In summary, the NOACs simplify oral anticoagulation and have the potential to increase the
uptake of anticoagulation for long-term prevention of thromboembolic events in patients with …

… , non-VKA oral anticoagulants (NOACs) were at least as effective and safe for the treatment
of acute venous thromboembolism as warfarin. Here, we review the efficacy and safety of …

… We aimed at defining the efficacy and safety of double antithrombotic therapy with single
antiplatelet therapy (SAPT) plus a non–vitamin K antagonist oral anticoagulant (NOAC) against …

… assess the overall frequency of oral anticoagulant-related major bleeding in the elderly.
Therefore, studies are included if they evaluated an oral anticoagulant (warfarin, acenocoumarol …